The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and potentially unreliable paper-based ...

The Food and Drug Administration's (FDA) drug review arm has proposed withdrawing approval for Amgen Inc.’s AMGN Tavneos ...

Artificial intelligence is no longer an emerging technology—it is an embedded reality shaping the way we live, govern and do business. From predictive healthcare to autonomous defense systems, AI is ...

Data is one of an organization’s most valuable assets, yet it is one of its most vulnerable, and AI is introducing more risk.

Since linked documents can be modified after being linked to a communication, preserving the state of the document as it was at the time of the original communication can range from difficult to ...